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ABSTRACT Chromosomal RNA was isolated from
several rat tissues by a new technique. It is shown by
RNA-DNA hybridization that each tissue contains a dis-
tinct population of chromosomal RNA sequences. This
finding is compatible with the proposal that chromosomal
RNA is involved in the process of gene activation.
Chromosomal RNA (cRNA) is a class of nuclear RNA
distinguished by its sequence diversity, small size, and high
dihydropyrimidine content (1). Several experiments suggest
that this RNA, apparently found in all eukaryotes, provides
the specificity of gene control (2, 3). Assuming this to be true,
there can be only two possibilities; cRNA is either a gene
activator or a gene repressor.
In a typical eukaryotic cell, 90% or more of the genes are
repressed. Thus, when one cell type is compared with another,
the active genes are usually different, but the repressed genes
are largely shared. Any gene regulator must reflect the genes it
controls. Thus, it follows that if cRNA is an activator, every
tissue should contain a distinctive set of cRNA sequences. If,
on the other hand, it is a repressor, the cRNA sequences should
be much the same from tissue to tissue. The hybridization
data presented in this paper clearly show that the cRNA
sequences of the rat tissues investigated are quite different.
This result is consistent with the hypothesis that cRNA is a
gene activator.
MATERIALS AND METHODS
Tissues. All tissues were obtained from 200-400 g, male,
albino rats of the Sprague-Dawley strain purchased from
Berkeley Pacific Laboratories. Regenerating livers were pro-
duced by surgical removal of the two largest lobes of the rats'
livers by the method of Higgins and Anderson (4). Novikoff
ascites-tumor cells were obtained from rats injected 6 days
earlier with 0.5 ml of ascites fluid. The tumor line was main-
tained by serial transfer of 0.5 ml of ascites fluid on a 6-day
cycle.
Chromatin. Crude chromatin was isolated from the solid
tissues, as described by Marushige and Bonner (5), with three
final washes in 0.01 M Tris HCl buffer (pH 8). Nuclei were
made from the ascites tumor cells with 0.5%7O Triton X-100 in
saline-EDTA buffer (0.75 M NaClI-.024 M EDTA, pH 8),
and chromatin was isolated from the nuclei by three cycles of
Abbreviations: DOC, deoxycholate; SSC, standard saline citrate
(0.15 M NaCl-0.015 M Na citrate).
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homogenization in a glass-Teflon homogenizer, followed by
centrifugation at 10,000 rpm for 10 min, all in 0.01 M Tris-
HCl buffer (pH 8).
Preparation of Chromosomal RNA (cRNA). cRNA was
prepared from crude chromatin in two ways. The first, termed
the "CsCl method", was exactly as described by Dahmus and
McConnell (6). Chromatin was made 4 M in CsCl by the
addition of 6 M CsCl-0.1 M Tris * HCl (pH 8), and centrifuged
for 12-20 hr at 36,000 rpm in the Spinco 40 rotor. Protein
floats to the top to form a pellicle or "skin", and cRNA is
obtained from this skin by Pronase digestion, phenol extrac-
tion, and elution from DEAE-Sephadex A-25 with a 0.2-1 M
NaCl gradient, all in 7 M urea. cRNA elutes as a sharp, sym-
metrical peak at 0.55 M NaCl. This method works very well
for ascites tumor, but poorly for rat liver, and not at all for rat
kidney. A second method was, therefore, developed.
This method, which will be referred to as the "DOC
method", yields cRNA reliably from all tissues investigated.
An equal volume of 1.7 M sucrose (enzyme grade, Mann Re-
search) is added to the crude chromatin and the mixture is
homogenized in a glass-Teflon homogenizer (3-5 strokes).
Then, with constant stirring, 0.3 M sodium deoxycholate, is
added dropwise, to a final concentration of 15 mMi and the
mixture is stirred for an additional 30 min at 40C. It is next
centrifuged at 36,000 rpm for 6-12 hr in the Spinco 40 rotor.
The supernatant is decanted and made 7 M in urea and 0.2 M
in NaCl by the addition of solid urea and NaCl. DEAE-
Sephadex, preequilibrated with 7 M urea-0.2M NaCl, is then
stirred in and a 0.9 X 20 cm column (10-50 g of tissue) is
poured with the slurry. When the column has been poured and
all the liquid has passed through, the cRNA is eluted with a
0.2-1 M NaCl gradient in 7 M urea. As with the CsCl method,
the cRNA comes off in a homogeneous peak at 0.55 M NaCl.
The RNA is routinely eluted a second time from DEAE-
Sephadex to remove residual impurities. All cRNA prepared
by this method that was used for RNA-DNA hybridization on
filters was then treated with Pronase, extracted with phenol,
and precipitated with ethanol. If the RNA was not treated
with Pronase, it bound nonspecifically to the nitrocellulose
filters during the hybridization reaction, presumably because
of the small amount of protein associated with it.
In Vitro Labeling of cRNA. cRNA was labeled in vitro by
the addition of 1 mCi of [3H]dimethylsulfate (New England
Nuclear Corp., 100-900 Ci/mol) to 1 mg or less of cRNA in
0.2 ml of sodium phosphate buffer (pH 7.6), made with glass-
distilled water (7). Incubation was performed for 6-12 hr at
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TABLE 1. Protein content of DOC-extracted cRNA from
several tissues
Tissue Protein, (%)
Calf thymus 7.3
Rat liver 5.0
Rat kidney 8.2
Ascites tumor* 1 .0
* Treated with Pronase.
room temperature. The RNA was recovered by ethanol pre-
cipitation and passage through a 2.5 X 30 cm Sephadex G-25
column.
RNA-DNA Hybridization. Denatured DNA was im-
mobilized on nitrocellulose filters (Schleicher and Schuell,
B-6, 12 mm) as described by Gillespie and Spiegelman (8).
10 /Ag of "4C-labeled DNA from the rat was applied to each fil-
ter in 6 X SSC (0.90 M NaCl-0.090M sodium citrate). Reten-
tion was normally about 70%.
Hybridizations were done at 37"C in 50% formamide and
5 X SSC (0.75 M NaCl-0.075 M Na citrate); this tempera-
ture is about 220C below the melting temperature of native rat
DNA in this solution (9). Each reaction was performed in
0.2 ml of RNA solution with two DNA filters and one blank
filter in each reaction vial. At the end of the desired incubation
time, the filters were removed, washed in 2 X SSC (0.30 M
NaCl-0.030 M Na citrate), digested with RNase (boiled pan-
creatic-ribonuclease A), washed again in 2 X SSC, dried, and
counted in a Beckman liquid-scintillation spectrometer.
Chemical Analysis. Protein analysis was done by the method
of Lowry et al. (10), with bovine-serum albumin as a standard.
Ureido groups were analyzed by the method of Ceriotti and
Spandrio (11) on RNA freed of all traces of urea by passage
through Sephadex G-25.
Determination of the Half-Life of cRNA In Vivo. The
method of Quincy and Wilson (12) was followed. Rats that
had been infected with ascites-tumor cells for 5 days were
injected intraperitoneally with 25 or 50 1ACi of [3H]orotic acid
(17 Ci/mmol); after 2 hr, each rat was injected with 10 mg of
unlabeled orotic acid. Ascites fluid was harvested at the de-
sired time after labeling, cRNA was made from the ascites
cells, and the specific activity of the cRNA was determined. A
plot of the log of the specific activity versus time gave the
apparent half-life of the RNA in vivo.
TABLE 2. Yields of cRNA (in % of DNA) extracted from
various chromatins by two different methods
CsCl Total
after cRNA
Tissue CsCl DOC DOC present
Ascites 4 2.5 2.5 5
Liver 0.1 2 0.1 2
4-hr Regenerating
liver 2 2 0.1 2
10-hr Regenerating
liver 3 1.5 0.8 3
Kidney 0 0.8 0 0.8
TABLE 3. Amounts of cRNA (in % of DNA) extracted from
ascites chromatin by different concentrations of DOC
DOC concentrations, (%)
0.01 0.015 0.02 0.03 0.05
DOC supernatant 3 2.5 1.7 1.8 Chromatin
CsCl-extracted destroyed
DOC pellet 2.3 2.5 2.6 3.2 DNA does not pel-
let under these
conditions
Rot. The term Rot has been introduced for RNA-DNA
hybridization reactions inwhichRNA is present in great excess.
The term is strictly analogous to the well-established Cot,
which has been defined for DNA-DNA hybridization reac-
tions (13). Rot stands for the concentration of RNA nucleo-
tides in mol/liter times the time in seconds. The term has been
introduced for convenience, and to avoid confusion with Cot,
which cannot properly be used forRNA-DNA reactions.
RESULTS
Properties of cRNA isolated with DOC
Chromosomal RNA, isolated by either the DOC or the CsCl
method, is characterized by its relatively small and uniform
size as determined by chromatography on DEAE-Sephadex.
Both methods give anRNA that elutes from DEAE-Sephadex
at 0.55 NaCl in 7 M urea, and that contains about 8% of
ureido-positive material by the colorometric test of Ceriotti
and Spandiio (11). Several studies show that cRNA is some-
times bound covalently to protein (14, 15). In contrast to these
findings, DOC-extracted cRNA, twice purified oIn DEAE-
Sephadex, contains only a small amount of protein (Table 1);
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FIG. 1. Comparison of the decay kinetics of ascites cRNA in
vivo isolated by both the CsCl method (-) and the DOC method
(X). It is apparent that both methods give RNA that decays as a
single component, with an apparent half-life of 8.5 hr. In these
experiments, the ascites cells had a generation time of 17 hr, so
that the real half-life of asictes cRNA (corrected for a doubling
of mass every 17 hr) is also 17 hr.
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FIG. 2. Hybridization-saturation data that compare DOG-
extracted and CsCl-extracted cRNA from liver and ascites
tumor.
it is not known whether or not this protein is covalently bound
to the RNA. It is possible that cRNA exists in the cell in both
the bound and unbound states, and that only the protein-
bound cRNA is isolated by the CsCl method. This hypothesis
is borne out to some extent by the data of Table 2, which lists
the yield of cRNA isolated by the two methods. 15mM is such
a low concentration of detergent that the chromatin is still
intact in the pellet after extraction with DOC (16). The pellet
may, therefore, be further extracted by the CsCl method. The
results of this second cRNA isolation are given in the third
column of Table 2. We were concerned that the large amount
of cRNA from ascites tumor that is not extractable with
15mM DOC might be simply an artifact of this particular con-
centration of detergent, but Table 3 shows that there appear
to be two classes of cRNA present over a fairly wide range of
DOC concentration. Although the proportions of the two
classes are variable with different preparations, on the whole
there appear to be about equal proportions of cRNA that are
and are not extractable from ascites chromatin by low concen-
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TABLE 4. % of DNA hybridized at saturation by cRNAs
of various tissues
Tissue RNA/DNA (%)
4-hr Regenerating liver 5.4
Ascites tunmor 4.9
Liver 2.2
Kidney 2.2
trations of DOC. The situation is much the same for regenerat-
ing liver, except that the proportion of the two classes changes
with time (Table 2). If cRNA does exist in two states, how-
ever, they are part of a common pool. This is shown quite
clearly by the data of Fig. 1, in which the logarithm of the
specific activity of cRNA isolated at various times from rats
that had received injections of [3H]orotic acid is plotted
against time. It is clearly seen that the decay rate of DOC-
extracted cRNA in vivo is indistinguishable from that of CsCl-
isolated cRNA.
The proof that cRNA isolated by the DOC method contains
the same sequences as cRNA isolated by the CsCl method
rests on the finding that their RNA-DNA hybridization
kinetics are identical. Fig. 2 shows that the hybridization-
saturation values are not affected by the method of isolation of
either rat liver or ascites-tumor cRNA. Fig. 3 shows that
DOC-isolated cRNA from rat liver competes well with CsCl-
isolated cRNA from the same tissue.
Hybridization data for cRNA isolated from various
tissues of the rat
Fig. 4 shows RNA-DNA hybridization saturation data from
four rat tissues. When RNA is in great excess, this reaction is
expected to follow approximate first-order reaction kinetics.
The lines are produced by a simple computer program that fits
a first-order saturation curve to each set of experimental data.
The hybridization saturation values calculated from this fit
are given in Table 4. The validity of this procedure rests on the
assumption that the RNA sequences are all present in about
the same concentration. This is almost certainly not true. The
saturation values should thus be taken as minimum values,
since rare RNA sequences will hybridize only at higher Rot
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FIG. 3. Hybridization competition between CsCl-extracted
[3HI cRNA from liver (Rot = 55) and different amounts of un-
labeled, DOC-extracted liver cRNA.
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FIG. 4. Hybridization-saturation curves for rat-liver cRNA
(0), rat-kidney cRNA (+), rat Novikoff ascites-tumor cRNA
(0), and 4-hr regenerating rat-liver cRNA (A). The curves are
first-order reaction kinetics fit by a computer to the data.
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FIG. 5. Hybridization-competition comparison of cRNA from
different tissues. (A) labeled liver cRNA (Rot = 20) com-
peted by unlabeled ascites-tumor cRNA. (0) labeled kidney
cRNA (Rot = 30) competed by unlabeled liver cRNA.
values. However, unless more than half of the cRNA se-
quences present in liver and kidney are present in exceedingly
low concentrations, it is clear that ascites and regenerating
liver contain cRNA sequences not present in liver or kidney.
Fig. 5 shows, in addition, that about half of the sequences of
kidney cRNA are absent or are present in very low concentra-
tion in rat liver, whereas nearly all of the liver sequences are
included in the cRNA isolated from ascites tumor. Perhaps
this last result is not too surprising, since Novikoff ascites
tumor was originally a hepatoma.
Thus, we conclude from hybridization competition that
kidney contains cRNA sequences not present in liver, and
from hybridization saturation that ascites tumor and regen-
erating-liver cells contain cRNA sequences not present in
normal liver or kidney cells. These results are consistent with
those of Bonner and Widholm (17), which show that cRNA
from pea buds differ from cRNA from pea cotyledons.
DISCUSSION
Several experiments have shown that cRNA is necessary for
gene-specific reconstitution of isolated chromatin (2, 3). It is a
short step to suppose that this cRNA is also responsible for
gene regulation in vivo. Since in a typical mammalian tissue
90% or more of the genes are repressed, and since all higher
eukaryotic cells contain histones that are almost certainly non-
specific repressors, it is probable that for the sake of efficiency,
cells specifically activate those genes that are needed rather
than to specifically repress those that are not. Any class of
RNA responsible for gene activation must be composed of a
distinctive set of sequences for each tissue type that cor-
respond to the distinctive set of proteins that give a tissue its
characteristics. In contrast, an RNA class responsible for gene
repression should appear quite similar by the hybridization
criterion when various cell types are compared, since nearly
all of the repressed genes are contained in common by any two
tissues.
Together with the known facts that cRNA is comple-
mentary to the middle repetitive-DNA sequences (18) and has
a convenient length of about 50 bases (1), these findings are
consistent with the hypothesis that cRNA provides one
mechanism for introducing specificity of gene activation in
higher creatures.
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